Archivio istituzionale della ricerca dell'Università degli Studi di Palermo

LICATA, Anna
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 16.379
EU - Europa 8.872
AS - Asia 7.230
SA - Sud America 1.090
AF - Africa 265
OC - Oceania 28
Continente sconosciuto - Info sul continente non disponibili 18
Totale 33.882
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 16.135
SG - Singapore 2.516
RU - Federazione Russa 2.443
IT - Italia 2.403
CN - Cina 1.954
HK - Hong Kong 882
FI - Finlandia 881
BR - Brasile 854
DE - Germania 683
VN - Vietnam 639
PL - Polonia 441
UA - Ucraina 370
GB - Regno Unito 357
IE - Irlanda 342
FR - Francia 341
JP - Giappone 204
IN - India 196
BD - Bangladesh 171
SE - Svezia 156
KR - Corea 136
CA - Canada 113
NL - Olanda 104
TR - Turchia 96
MX - Messico 87
RO - Romania 66
AR - Argentina 63
AT - Austria 58
ES - Italia 56
IQ - Iraq 55
ZA - Sudafrica 53
MA - Marocco 50
BE - Belgio 44
ID - Indonesia 41
PK - Pakistan 37
UZ - Uzbekistan 37
CL - Cile 36
EC - Ecuador 34
CI - Costa d'Avorio 32
VE - Venezuela 31
IR - Iran 30
KE - Kenya 27
EG - Egitto 26
AZ - Azerbaigian 25
CZ - Repubblica Ceca 23
DZ - Algeria 22
NP - Nepal 22
PH - Filippine 22
AE - Emirati Arabi Uniti 21
MY - Malesia 21
CO - Colombia 20
AU - Australia 19
SA - Arabia Saudita 18
JO - Giordania 17
BG - Bulgaria 15
PY - Paraguay 15
PE - Perù 13
BO - Bolivia 12
CH - Svizzera 12
EU - Europa 12
KZ - Kazakistan 12
ET - Etiopia 11
LB - Libano 11
TN - Tunisia 11
LT - Lituania 10
TH - Thailandia 10
NZ - Nuova Zelanda 9
PT - Portogallo 9
RS - Serbia 9
PA - Panama 8
TW - Taiwan 8
UY - Uruguay 8
AL - Albania 7
JM - Giamaica 7
QA - Qatar 7
SN - Senegal 7
BH - Bahrain 6
DO - Repubblica Dominicana 6
GR - Grecia 6
HN - Honduras 6
HU - Ungheria 6
AO - Angola 5
DK - Danimarca 5
IL - Israele 5
SI - Slovenia 5
AM - Armenia 4
BN - Brunei Darussalam 4
BY - Bielorussia 4
EE - Estonia 4
PS - Palestinian Territory 4
TG - Togo 4
XK - ???statistics.table.value.countryCode.XK??? 4
BB - Barbados 3
CY - Cipro 3
GA - Gabon 3
GE - Georgia 3
GY - Guiana 3
KG - Kirghizistan 3
MD - Moldavia 3
MM - Myanmar 3
NI - Nicaragua 3
Totale 33.838
Salva come PNG Salva come JPEG
Città #
Fairfield 2.048
Ashburn 2.032
Singapore 1.703
Chandler 1.009
Woodbridge 950
Seattle 800
San Jose 795
Houston 781
Wilmington 781
Cambridge 687
Hong Kong 652
Ann Arbor 500
Palermo 415
Zgierz 384
Council Bluffs 375
Dublin 341
Moscow 336
Beijing 332
Los Angeles 274
Medford 269
New York 244
Helsinki 232
Des Moines 230
Ho Chi Minh City 228
Altamura 210
Nanjing 195
Tokyo 178
Princeton 173
Jacksonville 171
Lauterbourg 171
Santa Clara 170
Hanoi 160
The Dalles 157
Lawrence 150
Frankfurt am Main 145
Milan 145
San Diego 134
Dallas 129
Dearborn 106
Hefei 103
Rome 92
Jinan 91
Buffalo 82
São Paulo 79
Boardman 78
Chicago 77
Tulsa 75
Nanchang 73
Shenyang 71
Nuremberg 68
London 67
Phoenix 65
Orem 63
Tianjin 59
Changsha 55
Ludwigshafen am Rhein 55
Hebei 53
Munich 49
Columbus 48
Izmir 47
Amsterdam 45
Guangzhou 44
Brussels 42
Naples 42
Ningbo 41
Jiaxing 40
Atlanta 39
Mumbai 39
Warsaw 39
Zhengzhou 37
Chennai 35
Redwood City 35
Falls Church 33
Abidjan 32
Da Nang 32
Vienna 31
Johannesburg 30
Casablanca 28
Denver 28
Kumar 27
San Paolo di Civitate 27
Haiphong 26
Manchester 26
Montreal 26
Seongnam 26
Bremen 25
Brooklyn 25
Florence 24
Hangzhou 24
Poplar 24
Saint Petersburg 24
Lappeenranta 23
Nairobi 23
Rio de Janeiro 23
Taizhou 23
Toronto 23
Venice 23
Verona 23
Baku 22
Lanzhou 22
Totale 21.443
Salva come PNG Salva come JPEG
Nome #
MODIFICAZIONI ECOGRAFICHE DELLA LINFADENOPATIA DELL’ILO EPATICO DOPO ERADICAZIONE DELL’HCV CON DIRECT-ACTING ANTIVIRALS 546
PRESENTAZIONE ECOGRAFICA DELL’EPATOCARCINOMA: ESPERIENZA DI UN SINGOLO CENTRO NELL’ARCO DI TRE DECENNI 400
Clinical manifestations and outcome predictors of SARS-COV2 disease (COVID-19): experience of a single center. 392
Hepatitis C Virus Eradication by Direct Antiviral Agents Improves Carotid Atherosclerosis in patients with Severe Liver Fibrosis 387
A phenobarbital overdose: a case report 373
Acute polymyositis during treatment of acute hepatitis C with pegylated interferon alpha-2b 326
HBV reactivation in patients with HCV/HBV cirrhosis on treatment with direct-acting antivirals 324
Reactive hyperemia index (RHI) and cognitive performance indexes are associated with histologic markers of liver disease in subjects with non-alcoholic fatty liver disease (NAFLD): a case control study. 301
Clinical course and genetic susceptibility of primary biliary cirrhosis: Analysis of a prospective cohort 299
Clinical course and management of acute and chronic viral hepatitis during pregnancy. 293
The presence of white matter lesions is associated with the fibrosis severity of nonalcoholic fatty liver disease 292
Early carotid atherosclerosis and cardiac diastolic abnormalities in hypertensive subjects 283
Hospital Care of Older Patients With COPD: Adherence to International Guidelines for Use of Inhaled Bronchodilators and Corticosteroids 273
Characteristics of liver cirrhosis in Italy: Evidence for a decreasing role of HCV aetiology 272
Platelet Count Does Not Predict Bleeding in Cirrhotic Patients: Results from the PRO-LIVER Study 270
Clinical course and outcomes of drug-induced liver injury: Nimesulide as the first implicated medication. 269
Obstructive Sleep Apnea Is Associated with Liver Damage and Atherosclerosis in Patients with Non-Alcoholic Fatty Liver Disease 269
751 RETINOL-BINDING PROTEIN 4 (RBP4): A NEW MARKER OF G1 HCV-INDUCED STEATOSIS 262
Surveillance program for diagnosis of hcc in liver cirrhosis: Role of ultrasound echo patterns 261
EFFETTI DELLA TERAPIA CON DIRECT ACTING ANTIVIRALS (DAAS) SUI PARAMETRI ECOGRAFICI DI IPERTENSIONE PORTALE 260
Clinical implications of the hyperdynamic syndrome in cirrhosis. 254
PNPLA3 GG Genotype and Carotid Atherosclerosis in Patients with Non-Alcoholic Fatty Liver Disease 251
Expression of cytokeratin 7 and 20 in pathological conditions of the bile tract 251
Elderly Onset Celiac Disease: A Narrative Review. 249
C4BQ0: a genetic marker of familial HCV-related liver cirrhosis. 245
Carotid atherosclerosis and chronic hepatitis C: A prospective study of risk associations. 245
Clinical features and outcomes of patients with drug-induced autoimmune hepatitis: A retrospective cohort study. 245
Subclinical cardiovascular damage in patients with HCV cirrhosis before and after treatment with direct antiviral agents: a prospective study 245
Direct acting antivirals after successful treatment of early hepatocellular carcinoma improve survival in HCV-cirrhotic patients 244
Serum BLyS/BAFF predicts the outcome of acute hepatitis C virus infection 242
Mortality rate and risk factors for gastrointestinal bleeding in elderly patients 242
The course of oesophagogastric varices in patients with cirrhosis after DAA-induced HCV clearance 238
Acute hepatitis C: in search of the optimal approach to cure. 237
Nontumorous portal vein thrombosis in liver cirrhosis: Possible role of β-blockers 234
Clinical trial: High-dose furosemide plus small-volume hypertonic saline solutions vs. repeated paracentesis as treatment of refractory ascites. 232
Survival of patients with hepatocellular carcinoma in cirrhosis: a comparison of BCLC, CLIP and GRETCH staging systems 231
Rivaroxaban-induced hepatotoxicity: review of the literature and report of new cases 227
Need for Deprescribing in Hospital Elderly Patients Discharged with a Limited Life Expectancy: The REPOSI Study 227
Retinol-binding protein 4 (RBP4) : a new marker of G1 HCV-induced steatosis 226
Inflammation and Aortic Stiffness: An Individual Participant Data Meta-Analysis in Patients With Inflammatory Bowel Disease. 226
Can chemotherapy concomitantly delivered with radiotherapy improve survival of patients with resectable rectal cancer? A meta-analysis of literature data 225
Imaging features of pancreatic metastases: A comparison with pancreatic ductal adenocarcinoma 224
A patient with acute hepatitis C and possible IFN toxicity [2] 222
Preoperative chemoradiotherapy for oesophageal cancer: a systematic review and meta-analysis 221
Sarcopenia is associated with severe liver fibrosis in patients with non-alcoholic fatty liver disease 220
Treatment of hepatocellular carcinoma in compensated cirrhosis with radio-frequency thermal ablation (RFTA): a prospective study 219
The Changing Epidemiology of Hepatocellular Carcinoma :  Experience of a Single Center 219
Serology in adults with celiac disease: limited accuracy in patients with mild histological lesions. 217
Retinol-binding protein 4: a new marker of virus-induced steatosis in patients infected with hepatitis C virus genotype 1. 216
Genetic association of interleukin-6 polymorphism (-174 G/C) with chronic liver diseases and hepatocellular carcinoma. 216
The impact of radiotherapy on survival in resectable gastric carcinoma: A meta-analysis of literature data. 213
Relationship between circulating E-selectin, DD genotype of angiotensin-converting-enzyme, and cardiovascular damage in central obese subjects 212
Disease outcomes after DAA-induced SVR: Data from the resist-HCV cohort 211
Plasma adiponectin: A contributing factor for cardiac changes in visceral obesity-associated hypertension 211
A woman with a long history of abdominal pain 211
Undetectable HCV-RNA at treatment-week 8 results in high-sustained virological response in HCV G1 treatment-experienced patients with advanced liver disease: The International Italian/Spanish Boceprevir/Peginterferon/Ribavirin Name Patients Program 209
Serum BLYS/BAFF levels in acute hepatitis C predict clinical outcome 204
Genetic predisposition to thrombophilia in inflammatory bowel disease 204
Polypharmacy in older people: lessons from 10 years of experience with the REPOSI register 204
A Case of Fatal Drug Rash Eosinophilia and Systemic Symptoms from Allopurinol 203
Cardiac involvement in rheumatoid arthritis: evidence of silent heart disease 202
Case report: acute portal vein thrombosis associated with acute cytomegalovirus infection in an immunocompetent adult 202
Renal function is impaired in normotensive chronic HCV patients: role of insulin resistance 201
Is vitamin D deficiency predictor of complications development in patients with HCV-related cirrhosis? 198
Economic Consequences of Investing in Anti-HCV Antiviral Treatment from the Italian NHS Perspective: A Real-World-Based Analysis of PITER Data 197
Hepatitis C Virus Infection Is Associated With Increased Cardiovascular Mortality: A Meta-Analysis of Observational Studies 196
Epidemiology, Diagnosis, and Non-Pharmacological Treatment of HCC 194
Increased expression of markers of early atherosclerosis in patients with inflammatory bowel disease 193
Incidence of Hepatocellular Carcinoma in Patients With HCV-Associated Cirrhosis Treated With Direct-Acting Antiviral Agents 193
Direct-acting antivirals after successful treatment of early hepatocellular carcinoma improve survival in HCV-cirrhotic patients 193
DRUG INDUCED LIVER INJURIES BY TICAGRELORSTATINS INTERACTION: A CASE REPORT 193
Lymphocyte beta-adrenergic receptors in young subjects with peripheral or central obesity: relationship with central haemodynamics and left ventricular function 192
COMEPA (COVID-19 Medicina Policlinico Palermo): a study in hospitalized patients. 192
Is Transient Elastography Needed for Noninvasive Assessment of High-Risk Varices? the REAL Experience 191
Practice guidelines for the treatment of hepatitis C: recommendations from an AISF/SIMIT/SIMAST Expert Opinion Meeting. 190
Retreatment with pegylated interferon plus ribavirin of chronic hepatitis C non-responders to interferon plus ribavirin: A meta-analysis. 189
Competing risks and prognostic stages of cirrhosis: A 25-year inception cohort study of 494 patients 189
Effetti cardioprotettivi del Blocco del Sistema Renina-Angiotensina-Aldosterone tramite l’associazione ACE-inibitore – Sartani: Relazione con i livelli circolanti di Transforming Growth Factor ß1. 188
CLINICAL COURSE OF NIMESULIDE-INDUCED LIVER INJURY 188
Clinical course and prognostic factors of hepatorenal syndrome: A retrospective single-center cohort study 188
AISF position paper on liver disease and pregnancy. 188
Mortality in patients with hepatocellular carcinoma predicted by six scoring: none is the winner 187
Radio-frequency thermal ablation (RFTA) of small hepatocellular carcinoma in patients with cirrhosis. Experience at a single tertiary referral center 187
Prognostic indicators of successful endoscopic sclerotherapy for prevention of rebleeding from oesophageal varices in cirrhosis: a long-term cohort study. 186
Optimizing diagnostic approach to drug-induced liver injury 186
Fluoroquinolone-induced liver injury: three new cases and a review of the literature. 185
When and how to treat acute hepatitis C? 185
Cardiac involvement in patients with cirrhosis: a focus on clinical features and diagnosis 183
A focus on epidemiology of drug-induced liver injury: analysis of a prospective cohort 182
A questionable diagnosis in a woman with drowsiness 182
Treatment of hepatitis C: critical appraisal of the evidence 180
Association between reduced lymphocyte beta-adrenergic receptors and left ventricular dysfunction in young obese subjects 179
Liver and statins: a critical appraisal of the evidence 179
Weight-loss supplementation and acute liver failure: the case of Garcinia Cambogia 179
Patterns of infections in older patients acutely admitted to medical wards: data from the REPOSI register 179
Patologie da sovraccarico di ferro:recenti acquisizioni 177
Left ventricular filling abnormalities and obesity-associated hypertension: relationship with overproduction of circulating transforming growth factor beta1. 177
Herbal hepatotoxicity: a hidden epidemic 177
The presence of White Matter Lesions is not associated with Non-alcoholic Fatty Liver Disease but with its histological severity 176
Central obesity and hypertension: the role of plasma endothelin. Am J Hypertens 175
Totale 22.922
Salva come PNG Salva come JPEG
Categoria #
all - tutte 117.565
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 117.565
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021450 0 0 0 0 0 0 0 0 0 0 191 259
2021/20222.293 100 449 80 100 87 109 131 165 284 261 177 350
2022/20233.256 277 599 47 332 273 455 228 444 335 52 130 84
2023/20241.552 68 178 81 113 118 337 153 98 73 87 74 172
2024/20253.634 113 237 181 304 156 134 234 220 289 443 531 792
2025/202612.725 812 341 679 1.071 1.291 1.966 1.950 1.413 1.237 1.407 558 0
Totale 34.955